LY3819253
014 / ACTIV-3
Phase 3 mab completed
Quick answer
LY3819253 for Covid19 is a Phase 3 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Covid19
- Phase
- Phase 3
- Modality
- mab
- Status
- completed